|
|
Volumn 125, Issue 6, 2013, Pages 62-72
|
|
The safety and efficacy of lorcaserin in the management of obesity
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIOBESITY AGENT;
BENZAZEPINE DERIVATIVE;
LORCASERIN;
SEROTONIN 2 AGONIST;
SEROTONIN 2C RECEPTOR;
BODY COMPOSITION;
BODY WEIGHT;
DRUG EFFECTS;
HUMAN;
OBESITY;
PHASE 3 CLINICAL TRIAL (TOPIC);
WEIGHT REDUCTION;
ANTI-OBESITY AGENTS;
BENZAZEPINES;
BODY COMPOSITION;
BODY WEIGHT;
CLINICAL TRIALS, PHASE III AS TOPIC;
HUMANS;
OBESITY;
RECEPTOR, SEROTONIN, 5-HT2C;
SEROTONIN 5-HT2 RECEPTOR AGONISTS;
WEIGHT LOSS;
|
|
EID: 84891671541
PISSN: None
EISSN: 19419260
Source Type: Journal
DOI: 10.3810/pgm.2013.11.2713 Document Type: Review |
|
Times cited : (10)
|
|
References (0)
|